Non-invasive Prenatal Testing (NIPT) Market Segmentations, Share

The Non-Invasive Prenatal Diagnostics Market is anticipated to reach $13.1 billion by 2027 and expand at a CAGR of 17.1% between 2023 and 2032. An approach to assessing the likelihood that the foetus will be delivered with specific genetic abnormalities is non-invasive prenatal testing (NIPT). It examines tiny DNA strands that are present in an expectant woman’s blood.

The increase in the prevalence of chromosomal aneuploidies in foetuses, the development of advanced non-invasive parenteral testing products, and improvements in the reimbursement environment are the main causes of the growth in the non-invasive prenatal testing (NIPT) market. Additionally, growing consumer knowledge of non-invasive prenatal testing and untapped market potential in Asia’s emerging countries present significant opportunities for revenue growth for market participants.

Non-invasive parenteral screening, also referred to as non-invasive prenatal testing, is a developing genetic procedure that looks at foetal cell-free DNA present in the mother’s blood serum to find common foetal aneuploidies. Early detection of genetic diseases like trisomy 21 (Down syndrome), trisomy 18 (Edward syndrome), trisomy 13 (Patau syndrome), and monosomy X is its primary goal (Turner syndrome). Additionally, it can identify the fetus’s blood type and rhesus agent. NIPTs like MaterniT21 PLUS, Harmony, Panorama, NIFTY, PrenaTest, BambniTest, and others are presently offered on the international market.

The market is driven by an increase in NIPT reimbursements, a rise in the use of non-invasive procedures rather than invasive ones, and an increase in maternal age (which is linked to an increase in the chance of chromosomal abnormalities in offspring). The introduction and creation of cutting-edge, novel technologies as well as non-invasive parenteral testing products also contribute to the market’s expansion. However, a dearth of qualified professionals, strict regulatory requirements, and ethical barriers slow the approvals and marketing processes, which limits market development. The untapped growth of a new market in Asia-Pacific opens up opportunities for his industry to expand.

This report examines all the key factors influencing growth of global Non-invasive Prenatal Testing (NIPT) market, including demand-supply scenario, pricing structure, profit margins, production and value chain analysis. Regional assessment of global Non-invasive Prenatal Testing (NIPT) market unlocks a plethora of untapped opportunities in regional and domestic market places. Detailed company profiling enables users to evaluate company shares analysis, emerging product lines, scope of NPD in new markets, pricing strategies, innovation possibilities and much more.

Click Here To Access The Free Sample Report @ https://analyticsmarketresearch.com/sample-request/non-invasive-prenatal-testing-(nipt)-market/2792/

Market Segmentations:

Global Non-invasive Prenatal Testing (NIPT) Market: Major Players
PerkinElmer Inc.
NIPD Genetics
Quest Diagnostics
Illumina Inc.
Beijing Genomics Institute
F. Hoffmann-La Roche
Yourgene Health Plc
LifeCodexx AG
Laboratory Corporation of America Holdings (LabCorp)
Myriad Genetics Inc.
Natera Inc.
Next Biosciences (Pty) Limited

Global Non-invasive Prenatal Testing (NIPT) Market: Types
Consumables
Reagent
Ultrasound
NGS
PCR
Microarray

Global Non-invasive Prenatal Testing (NIPT) Market: Applications
Aneuploidy
Microdeletion

Global Non-invasive Prenatal Testing (NIPT) Market: Regional Analysis
All the regional segmentation has been studied based on recent and future trends, and the market is forecasted throughout the prediction period. The countries covered in the regional analysis of the Global Non-invasive Prenatal Testing (NIPT) market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium, and Rest of Europe in Europe, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), and Argentina, Brazil, and Rest of South America as part of South America.

Read Full Research Report @ https://analyticsmarketresearch.com/reports/non-invasive-prenatal-testing-(nipt)-market/2792/

The market is divided into segments based on the product, method, application, end users, and region in the study. It is divided into consumables and instruments based on the type of merchandise. Depending on the technique, it can be classified as foetal cells in maternal blood tests, cell-free DNA in maternal plasma tests, biochemical screening tests, and ultrasound detection. It can be divided into trisomy, microdeletion syndrome, and other uses depending on the application. The industry is examined in terms of geography across North America, Europe, Asia-Pacific, and LAMEA.

Key Benefits

The study provides an in-depth analysis of the non-invasive prenatal testing market, with current trends and future estimations to elucidate the imminent investment pockets.
It presents a quantitative analysis to enable the stakeholders to capitalize on prevailing market opportunities.
Extensive analysis of the market by product type elucidates various forms of non-invasive prenatal testing available.
Key players are profiled and their strategies are analyzed thoroughly, which predict the competitive outlook of the market.

COVID-19 Impact

The COVID-19 outbreak has altered the development expectations for many industries and companies. After the pandemic hit, the analysts at TMR Research diligently surveyed the markets. The study contains the brilliant and thoroughly researched views of the analysts. The stakeholders can better plan their strategy with the assistance of the opinions.

Reasons to Purchase this Report

Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post sales analyst support